158 related articles for article (PubMed ID: 1525190)
1. Asacol (mesalamine).
Claussen D
Gastroenterol Nurs; 1992 Aug; 15(1):33-4. PubMed ID: 1525190
[TBL] [Abstract][Full Text] [Related]
2. Oral mesalamine (Asacol) for mildly to moderately active ulcerative colitis. A multicenter study.
Sninsky CA; Cort DH; Shanahan F; Powers BJ; Sessions JT; Pruitt RE; Jacobs WH; Lo SK; Targan SR; Cerda JJ
Ann Intern Med; 1991 Sep; 115(5):350-5. PubMed ID: 1863024
[TBL] [Abstract][Full Text] [Related]
3. Asacol: mesalazine for ulcerative colitis.
Drug Ther Bull; 1986 May; 24(10):38-40. PubMed ID: 3709355
[No Abstract] [Full Text] [Related]
4. Mesalamine in ulcerative colitis.
Fitzgerald JM; Marsh TD
DICP; 1991 Feb; 25(2):140-5. PubMed ID: 1676200
[TBL] [Abstract][Full Text] [Related]
5. Is Asacol as effective as sulphasalazine in maintaining remission of Crohn's disease and ulcerative colitis?
Nakshabendi IM; Duncan A; Russell RI
Postgrad Med J; 1992 Mar; 68(797):189-91. PubMed ID: 1350343
[TBL] [Abstract][Full Text] [Related]
6. Oral 5-aminosalicylic acid preparations in treatment of inflammatory bowel disease. An update.
Martin F
Dig Dis Sci; 1987 Dec; 32(12 Suppl):57S-63S. PubMed ID: 2891469
[TBL] [Abstract][Full Text] [Related]
7. Pentasa (Mesalamine).
Claussen DW
Gastroenterol Nurs; 1993 Dec; 16(3):136-7. PubMed ID: 8286430
[TBL] [Abstract][Full Text] [Related]
8. An oral preparation of mesalamine as long-term maintenance therapy for ulcerative colitis. A randomized, placebo-controlled trial. The Mesalamine Study Group.
Ann Intern Med; 1996 Jan; 124(2):204-11. PubMed ID: 8533995
[TBL] [Abstract][Full Text] [Related]
9. Oral mesalamine for ulcerative colitis.
Med Lett Drugs Ther; 1992 Aug; 34(877):80-1. PubMed ID: 1353858
[No Abstract] [Full Text] [Related]
10. New oral salicylates in the therapy of chronic idiopathic inflammatory bowel disease.
Robinson MG
Gastroenterol Clin North Am; 1989 Mar; 18(1):43-50. PubMed ID: 2646221
[TBL] [Abstract][Full Text] [Related]
11. Experience with Eudragit-S-coated mesalamine (Asacol) in inflammatory bowel disease. An open study.
Faber SM; Korelitz BI
J Clin Gastroenterol; 1993 Oct; 17(3):213-8. PubMed ID: 8228082
[TBL] [Abstract][Full Text] [Related]
12. Oral asacol in the treatment of mild to moderate ulcerative colitis: the Nashville experience.
Pruitt RE; Gremillion DE; Herring RW; Bailey AH; Faust TW; Potter M; Long KM
J Tenn Med Assoc; 1991 May; 84(5):237. PubMed ID: 2067380
[No Abstract] [Full Text] [Related]
13. Role of mesalazine in acute and long-term treatment of ulcerative colitis and its complications.
Schroeder KW
Scand J Gastroenterol Suppl; 2002; (236):42-7. PubMed ID: 12408503
[TBL] [Abstract][Full Text] [Related]
14. Oral 5-aminosalicylic acid for induction of remission in ulcerative colitis.
Feagan BG; Macdonald JK
Cochrane Database Syst Rev; 2012 Oct; 10():CD000543. PubMed ID: 23076889
[TBL] [Abstract][Full Text] [Related]
15. Pleuropericarditis in a patient with ulcerative colitis in longstanding 5-aminosalicylic acid therapy.
Iaquinto G; Sorrentini I; Petillo FE; Berardesca G
Ital J Gastroenterol; 1994 Apr; 26(3):145-7. PubMed ID: 8061342
[TBL] [Abstract][Full Text] [Related]
16. Discovery and preclinical development of a novel prodrug conjugate of mesalamine with eicosapentaenoic acid and caprylic acid for the treatment of inflammatory bowel diseases.
Kandula M; Sunil Kumar KB; Palanichamy S; Rampal A
Int Immunopharmacol; 2016 Nov; 40():443-451. PubMed ID: 27716592
[TBL] [Abstract][Full Text] [Related]
17. A randomized, double-blind, placebo-controlled trial of the oral mesalamine (5-ASA) preparation, Asacol, in the treatment of symptomatic Crohn's colitis and ileocolitis.
Tremaine WJ; Schroeder KW; Harrison JM; Zinsmeister AR
J Clin Gastroenterol; 1994 Dec; 19(4):278-82. PubMed ID: 7876505
[TBL] [Abstract][Full Text] [Related]
18. Treatment of ulcerative colitis with oral mesalamine: advances in drug formulation, efficacy expectations and dose response, compliance, and chemoprevention.
Sandborn WJ
Rev Gastroenterol Disord; 2006; 6(2):97-105. PubMed ID: 16699478
[TBL] [Abstract][Full Text] [Related]
19. Treatment of ulcerative colitis with oral 5-aminosalicylic acid including patients with adverse reactions to sulfasalazine.
Habal FM; Greenberg GR
Am J Gastroenterol; 1988 Jan; 83(1):15-9. PubMed ID: 2892391
[TBL] [Abstract][Full Text] [Related]
20. Release of 5-Aminosalicylic Acid (5-ASA) from Mesalamine Formulations at Various pH Levels.
Abinusawa A; Tenjarla S
Adv Ther; 2015 May; 32(5):477-84. PubMed ID: 25951927
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
